| MSD Merck Sharp & Dohme AG - Noxafil 100 mg, magensaftresistente Tablette | | 63240 | | 01 | | Noxafil 100 mg | | magensaftresistente Tablette | | J02AC04 | | Posaconazole | | 18.02.2015 | | |
| | Composition | | posaconazolum 100 mg, hypromellosi acetas succinas, cellulosum microcristallinum, hydroxypropylcellulosum, silica colloidalis hydrica, carmellosum natricum conexum corresp. natrium 2.29 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Gastric juice resistant tablets | | | | | Active Agent | Dose |
|---|
| Posaconazole | 100 mg |
| | BAG: Active Agent | Dose |
|---|
| Posaconazole | 100 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | color. | | | | color. | | | | | | | | | | Macrogol | 3350 | | | | | | | | | Überzug | | | | | | | | | | Talcum | | |
| |
| |
|
